🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-arm, phase I/II, single-center study with dos...
Status
Unknown
Location
National University Hospital
Start Date
2020-10-07
Trial ID
NCT04620954
Treatments Being Tested
In this study, patients will be randomized to one of three dose regimen gro...
Status
Terminated
Location
Gynecologic Oncology Associates
Start Date
2000-09
Trial ID
NCT00034372
Treatments Being Tested
This study is phase II, open label, clinical trial to determine the efficac...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Start Date
2022-07-05
Trial ID
NCT05407584
Treatments Being Tested
Study to evaluate the safety and activity of oregovomab and niraparib as a ...
Status
Active Not Recruiting
Location
Duke Cancer Center
Start Date
2022-07-25
Trial ID
NCT05335993
Treatments Being Tested
Study to compare the safety and efficacy of oregovomab versus placebo, admi...
Status
Active Not Recruiting
Location
Honor Health
Start Date
2020-08-25
Trial ID
NCT04498117
Treatments Being Tested
The study will compare the pharmacokinetic profile of OvaRex MAb-B43.13 asc...
Status
Terminated
Location
Women's Cancer Research Foundation
Start Date
2002-03
Trial ID
NCT00034138
Treatments Being Tested
This is a Phase Ib study to look at the combination of an antibody immuniza...
Status
Terminated
Location
Florida Hospital Cancer Institute
Start Date
2017-05-30
Trial ID
NCT03162562
Treatments Being Tested
An experimental treatment with OvaRex® MAb-B43.13 (oregovomab), called immu...
Status
Terminated
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00086632
Treatments Being Tested
This study will compare the time to disease relapse between OvaRex® MAb-B43...
Status
Terminated
Location
Comprehensive Cancer Institute
Start Date
2002-12
Trial ID
NCT00050375
Treatments Being Tested
This randomized clinical trial is studying the side effects of oregovomab a...
Status
Withdrawn
Location
Gynecologic Oncology Group
Start Date
2007-10
Trial ID
NCT00551265
Treatments Being Tested